| Cat.No. | Name | Information |
|---|---|---|
| M1973 | Ostarine (MK-2866) | Ostarine (GTx-024 and MK-2866) is an investigational selective androgen receptor modulator (SARM) with Ki of 3.8 nM. |
| M6033 | Dihydrotestosterone | Dihydrotestosterone is an androgen (male hormone). Specifically it's the strongest of the androgens. It can be used to construct animal models of polycystic ovary syndrome (PCOS). |
| M6105 | Testosterone | Testosterone is an androgen, which binds the androgen receptor. |
| M5565 | Dexmedetomidine HCl | Dexmedetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is used in veterinary medicine for its analgesic and sedative properties. |
| M5805 | Nandrolone | Nandrolone is a synthetic, anabolic steroid analog of testosterone. |
| M1839 | MDV3100 | MDV3100 is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. |
| M5764 | Medroxyprogesterone acetate | Medroxyprogesterone acetate (MPA) is a synthetic progestin and act as a potent progesterone receptor agonist, used to treat abnormal menstruation or irregular vaginal bleeding. |
| M2270 | Apalutamide (ARN-509) | Apalutamide (ARN-509) is a novel androgen receptor (AR) antagonist for the treatment of castration-resistant prostate cancer (CRPC). |
| M10306 | Bavdegalutamide (ARV-110) | Bavdegalutamide (ARV-110) is an oral, specific androgen receptor (AR) PROTAC degrader. |
| M57285 | Ar-V7-IN-1 | Ar-V7-IN-1 is a potent inhibitor of Ar-V7. AR-V7 is a hormone-independent splice variant of the androgen receptor. Ar-V7-IN-1 has the potential for the research of various indications such as prostate cancer. |
| M57283 | SC912 | SC912 is a potent and selective AR-V7 inhibitor with IC50 of 0.36 μM. SC912 binds directly to AR-FL and AR-V7 proteins, inhibites nuclear localization and chromatin binding capabilities. SC912 exerts anticancer activity through inhibition of proliferation, induction of cell cycle arrest and apoptosis. |
| M57282 | A4B17 | A4B17 is an androgen receptor N-terminal inhibitor, which can be used for the research of androgen-responsive prostate cancer. |
| M57242 | AZ'3137 | AZ‘3137 is an orally active PROTAC-type androgen receptor (AR) degrader, with a DC50 value of 22 nM. |
| M57241 | (R)-SKBG-1 | (R)-SKBG-1 is an RNA-binding protein NONO inhibitor. |
| M57240 | Cl-4AS-1 | Cl-4AS-1, a potent steroidal androgen receptor (AR) agonist (IC50 = 12 nM), is also an inhibitor of 5α-reductase types I and II (IC50 = 6 and 10 nM, respectively). |
| M57239 | Lubabegron fumarate | Lubabegron (LY-488756) fumarate is an antagonist of the adrenergic receptor (β-AR). |
| M57084 | ARD-1676 | ARD-1676 is an orally available androgen receptor (AR) PROTAC degrader, consisting of AR ligand and cereblon ligand. |
| M50384 | (Des-Glu5)-ACTH (1-24) (human, bovine, rat) | (Des-Glu5)-ACTH (1-24) (human, bovine, rat) is an analogue of Adrenocorticotropic hormone (ACTH). |
| M50383 | Acetyl-ACTH (2-24) (human, bovine, rat) | Acetyl-ACTH (2-24) (human, bovine, rat) is a fragment of proopiomelanocortin (POMC) peptide. |
| M50382 | Acetyl-ACTH (3-24) (human, bovine, rat) | Acetyl-ACTH (3-24) (human, bovine, rat) is a fragment of proopiomelanocortin (POMC) peptide. |
| M50381 | Acetyl-ACTH (4-24) (human, bovine, rat) | Acetyl-ACTH (4-24) (human, bovine, rat) is a fragment of proopiomelanocortin (POMC) peptide. |
| M50380 | Acetyl-ACTH (7-24) (human, bovine, rat) | Acetyl-ACTH (7-24) (human, bovine, rat) causes a marked decrease of ACTH-evoked corticosterone and aldosterone release. |
| M50379 | Adrenocorticotropic hormone | Adrenocorticotropic hormone (ACTH) is a polypeptide tropic hormone produced by the anterior pituitary gland. |
| M50378 | LH-RH II (chicken) | LH-RH II (chicken) is one of the two forms of luteinizing hormone-releasing hormone (LHRH) the hypothalamus of the domestic hen, which are structural variants of mammalian LHRH. |
| M43901 | TAS3681 | TAS3681 is an androgen receptor (AR) inhibitor that may be used in studies related to prostate cancer. |
| M43900 | ONC1-13B | ONC1-13B is an androgen receptor (AR) inhibitor that can be used in studies related to denervation-resistant prostate cancer (CRPC). |
| M43896 | Zanoterone | Zanoterone is an androgen receptor (AR) inhibitor that may be used in studies related to prostate cancer. |
| M43589 | Androgen receptor degrader-3 | Androgen receptor degrader-3 is an androgen receptor degrader. |
| M43588 | YXG-158 | YXG-158 is an orally active AR degrader and CYP17A1 inhibitor. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
